Is Donanemab a Breakthrough Treatment for Alzheimer’s?
Donanemab, developed by Eli Lilly, is an experimental antibody treatment targeting N3pG amyloid to slow cognitive decline in Alzheimer’s patients. Recently, an FDA advisory group…
Donanemab, developed by Eli Lilly, is an experimental antibody treatment targeting N3pG amyloid to slow cognitive decline in Alzheimer’s patients. Recently, an FDA advisory group…
Premium Content! You need GS Subscription to access this content. Join now to unlock premium content. JOIN NOW
Apple Intelligence, introduced at WWDC 2024, is a personal AI system integrated into iOS 18, iPadOS 18, and macOS Sequoia. It uses generative AI and…
Premium Content! You need GS Subscription to access this content. Join now to unlock premium content. JOIN NOW
Since the 2024 Lok Sabha elections, there has been a strong push for Andhra Pradesh to be given Special Category Status (SCS). The idea of…
Premium Content! You need GS Subscription to access this content. Join now to unlock premium content. JOIN NOW
India welcomed Egypt, Iran, UAE, Saudi Arabia, and Ethiopia as new BRICS members at a meeting in Russia. The BRICS ministers reaffirmed their commitment to…
Prime Minister Narendra Modi, after being re-elected for a third term, approved the 17th installment of the PM-KISAN scheme, disbursing Rs 20,000 crore to aid…
Premium Content! You need GS Subscription to access this content. Join now to unlock premium content. JOIN NOW
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.